Abstract
This work reports the synthesis and preliminary biodistribution results of [131I]SIB-PEG4-CHC in tumor-bearing mice. The tributylstannyl precursor ATE-PEG4-CHC was synthesized by conjugation of ATE to amino pegylated colchicine NH2-PEG4-CHC. [131I]SIB-PEG4-CHC was radiosynthesized by electrophilic destannylation of the precursor with a yield of ~44%. The radiochemical purity (RCP) appeared to be >95% by a Sep-Pak cartridge purification. [131I]SIB-PEG4-CHC was lipophilic and was stable at room temperature. Biodistribution studies in tumor-bearing mice showed that [131I]SIB-PEG4-CHC cleared from background rapidly, and didn’t deiodinate in vivo. However, the poor tumor localization excluded it from further investigations as a tumor-targeted radiopharmaceuticals.
Similar content being viewed by others
References
Graening T, Schmalz HG (2004) Angew Chem Int Ed Engl 43:3230–3256
Hendrikse NH, Franssen EJF, Van der Graaf WTA, Vaalburg W, de Vries EGE (1999) Eur J Nucl Med 26:283–293
Levchenko A, Mehta BM, Lee JB, Humm JL, Augensen F, Squire O, Kothari PJ, Finn RD, Leonard EF, Larson SM (2000) J Nucl Med 41:493–501
Zareneyrizi F, Yang DJ, Oh CS, Ilgan S, Yu DF, Tansey W, Liu CW, Kim EE, Podoloff DA (1999) Anticancer Drugs 10:685–692
Korde A, Satpati D, Mathur A, Mallia M, Banerjee S, Kothari K, Sarma HD, Choudhari P, Venkatesh M (2006) Bioorg Med Chem 14:793–799
EI-Azony KM, El-Mohty AA, Killa HM, Seddik U, Khater SI (2008) J Labelled Compd Radiopharm 52:1–5
Garg PK, Alston KL, Welsh PC, Zalutsky MR (1996) Bioconjug Chem 7:233–239
Zalutsky MR, Narula AS (1987) Appl Rad Isot 38:1051–1055
Zalutsky MR, Noska MA, Colapinto EV, Garg PK, Bigner DD (1989) Cancer Res 49:5543–5549
Vaidyanathan G, Zalutsky MR (1990) Bioconjug Chem 1:269–273
Matloobi M, Rafii H, Beigi D, Khalaj A, Kamali-Dehghan M (2003) J Radioanal Nucl Chem 257:71–73
Han Y, Yin D, Zheng M, Zhou W, Lee Z, Zhan L, Ma Y, Wu M, Shi L, Wang N, Lee J, Wang C, Lee Z, Wang Y (2010) J Radioanal Nucl Chem 284:279–286
Vaidyanathan G, Affleck DJ, Schottelius M, Wester H, Friedman HS, Zalutsky MR (2006) Bioconjug Chem 17:195–203
Roberts MJ, Bentley MD, Harris JM (2002) Adv Drug Deliv Rev 54:459–476
Harris JM, Chess RB (2003) Nat Rev Drug Discov 2:214–221
Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS, Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M (2004) J Nucl Med 45:1776–1783
Stephenson KA, Chandra R, Zhuang ZP, Hou C, Oya S, Kung MP, Kung HF (2007) Bioconjug Chem 18:238–246
Lagnoux D, Darbre T, Schmitz ML, Reymond JL (2005) Chemistry 11:3941–3950
Acknowledgments
The work was financially supported by National Natural Science Foundation of China (J0630962), the Fundamental Research Funds for the Central Universities (lzujbky-2009-22) and Chunhui Plan (Z2008-1-62018) Sponsored by Ministry of Education, China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zheng, X., Dong, F., Yang, J. et al. Synthesis and preliminary biodistribution studies of [131I]SIB-PEG4-CHC in tumor-bearing mice. J Radioanal Nucl Chem 287, 113–117 (2011). https://doi.org/10.1007/s10967-010-0659-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-010-0659-5